Figuring out cannabinoid effects

Post date: 2023-06-02 01:45:35
Views: 126
Looking for advice on avoiding occasional cannabis side effects.

I like to use marijuana products (mostly edibles, smoking, and vaping). Sometimes, not always, I experience one of two effects from certain types of these products: 1) consistent feelings of pessimism and doom, which feel different from standard weed paranoia or anxiety but may be related; 2) an allergic reaction of some kind, primarily congestion. I want to figure what is causing these reactions on a chemical level and avoid products containing that.

I often experience (1) with high-THC products such as concentrated weed gummies. Almost every time I take a gummy, regardless of brand, I end up in a multi-hour pit of despair. But just now I experienced it from a few puffs of a joint rolled with water hash. And the other "stoned" effects were pretty mild compared to the mood hit, so I don't think it's purely a matter of THC intensity, or is it? Regardless, what are some other edible products that might be better? CBD has pretty much no effect on me one way or the other.

(2) is usually associated with old, stale flower for me. I'm thinking it might be an allergy to CBN or THC oxide? Does that seem possible?
Please click Here to read the full story.
 
Other Top and Latest Questions:
The Trump administration equity portfolio is growing. These are the investments so far
First the quarter zip, now a '401(k) mullet' — what Gen Z trends say about the economy
Berkshire Hathaway outperforms this week as tech stocks sink
The new Bilt 2.0 cards are open for application. Here's how to decide which card is right for you
Pressure mounts on American Airlines CEO as carrier lags rivals
Super Bowl 60: Movie trailers and AI dominate ads; Bad Bunny halftime ahead
Elon Musk wants to be a trillionaire — here's how SpaceX may get him there
Tech giants in China sold off alongside their U.S. peers last week. How to play it
Japanese Prime Minister Takaichi's ruling LDP set to secure supermajority in Lower House: NHK
Goldman Sachs says this under-the-radar biotech play could more than double in value